CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 30 enrolled
Drug / intervention
Escitalopramdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00115011
NCT00115011Phase 4Completed
CompareCT.gov

Escitalopram for the Treatment of Self-Injurious Skin Picking

Massachusetts General Hospital·interventional·Posted Jun 21, 2005·Updated May 20, 2008

In Brief

A Phase 4 clinical trial evaluating Escitalopram for Impulse Control Disorders. Completed, enrolled 30 participants across 1 site.

Detailed Summary

The purpose of this study is to determine the effectiveness of escitalopram in treating self-injurious skin picking.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsImpulse Control Disorders
CountriesUnited States
CollaboratorsForest Laboratories

Timeline

Phase 4CompletedFinished
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJun 21, 2005
Enrollment StartSep 1, 2002
Study CompletionNov 1, 2005
TodayJul 2, 2026
Posted 21.0 years ago

Interventions

Escitalopramdrug